Wednesday, June 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “monoclonal”

203 pharma patents match "monoclonal" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 203
Index total 30,257
Page 6 / 9

Quick answer

This filtered view shows 203 pharmaceutical patents matching "monoclonal" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

203 results for “monoclonal” · 30,257 patents in full index Clear search

  1. US 8961975

    Monoclonal antibodies that neutralize anthrax toxins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted

  2. US 8956831

    Nucleic acids encoding a human monoclonal antibody that specifically binds to IL-1α

    XBIOTECH INC. · Granted Feb 17, 2015 · Expires Feb 12, 2035

    granted

  3. US 8877195

    Monoclonal antibodies to fibrin

    The Regents of the University of California · Granted Nov 4, 2014 · Expires Oct 30, 2034

    granted

  4. US 8865873

    Internalizing human monoclonal antibodies targeting prostate cancer cells in situ

    The Regents of the University of California · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  5. US 8859736

    Monoclonal antibodies that inhibit the wnt signaling pathway and methods of production and use thereof

    The Board of Regents of the University of Oklahoma · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  6. US 8858938

    Human monoclonal antibodies against Hendra and Nipah viruses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  7. US 8802090

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted

  8. US 8742075

    Monoclonal antibodies against ANGPTL3

    LEXICON PHARMACEUTICALS, INC. · Granted Jun 3, 2014 · Expires May 29, 2034

    granted

  9. US 8722046

    Human monoclonal antibodies protective against bubonic plague

    The United States of America as represented by the Secretary of the Army · Granted May 13, 2014 · Expires May 8, 2034

    granted

  10. US 8685396

    Monoclonal antibodies that neutralize anthrax protective antigen (PA) toxin

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  11. US 8673301

    YKL-40 monoclonal antibody

    The Regents of the University of California · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted

  12. US 8663950

    Production of a monoclonal antibody therapeutic against west nile virus in plants

    THE ARIZONA BOARD OF REGENTS · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted

  13. US 8598321

    Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

    The Regents of the University of California · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted

  14. US 8591889

    Human monoclonal antibodies specific for CD22

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted

  15. US 8591891

    Monoclonal antibodies against ANGPTL4

    LEXICON PHARMACEUTICALS, INC. · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted

  16. US 8574853

    Monoclonal antibodies that neutralize anthrax toxins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  17. US 8535639

    Trifunctional imaging agent for monoclonal antibody tumor-targeted imaging

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  18. US 8535667

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  19. US 8524456

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted

  20. US 8506961

    Humanized monoclonal antibodies that specifically bind and/or neutralize japanese encephalitis virus (JEV) and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted

  21. US 8507206

    Monoclonal antibodies that target pathological assemblies of amyloid β (Abeta)

    Acumen Pharmaceuticals, Inc. · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted

  22. US 8501182

    Monoclonal antibodies that react with the capsule of Bacillus anthracis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

  23. US 8470326

    Monoclonal antibody therapy for pancreas cancer

    PRECISION BIOLOGICS, INC. · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted

  24. US 8404818

    Monoclonal antibodies against orthopoxviruses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.